A RetroSearch Logo

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Search Query:

Showing content from https://pubmed.ncbi.nlm.nih.gov/21962263/ below:

Does the timing of esophagectomy after chemoradiation affect outcome?

Comparative Study

. 2012 Jan;93(1):207-12; discussion 212-3. doi: 10.1016/j.athoracsur.2011.05.021. Epub 2011 Oct 1. Does the timing of esophagectomy after chemoradiation affect outcome? Arlene M CorreaAra A VaporciyanJack A RothReza J MehranGarrett L WalshDavid C RiceJaffer A AjaniDipen M MaruManoop S BhutaniJames WelshEdith M MaromStephen G SwisherWayne L Hofstetter

Affiliations

Affiliation

Item in Clipboard

Comparative Study

Does the timing of esophagectomy after chemoradiation affect outcome?

Jae Y Kim et al. Ann Thorac Surg. 2012 Jan.

. 2012 Jan;93(1):207-12; discussion 212-3. doi: 10.1016/j.athoracsur.2011.05.021. Epub 2011 Oct 1. Authors Jae Y Kim  1 Arlene M CorreaAra A VaporciyanJack A RothReza J MehranGarrett L WalshDavid C RiceJaffer A AjaniDipen M MaruManoop S BhutaniJames WelshEdith M MaromStephen G SwisherWayne L Hofstetter Affiliation

Item in Clipboard

Abstract

Background: After neoadjuvant chemoradiation (CXRT) for esophageal cancer, surgery has traditionally been recommended to be performed within 8 weeks. However, surgery is often delayed for various reasons. Data from other cancers suggest that delaying surgery may increase the pathologic complete response rate. However, there are theoretical concerns that waiting longer after radiation may lead to a more difficult operation and more complications. The optimal timing of esophagectomy after CXRT is unknown.

Methods: From a prospective database, we analyzed 266 patients with resected esophageal cancer who were treated with neoadjuvant CXRT from 2002 to 2008. Salvage resections were excluded from this analysis. We compared patients who had surgery within 8 weeks of CXRT and those who had surgery after 8 weeks. We used multivariable analysis to determine whether increased interval between chemoradiation and surgery was independently associated with perioperative complication, pathologic response, or overall survival.

Results: One hundred fifty patients were resected within 8 weeks and 116 were resected greater than 8 weeks after completing CXRT. Mean length of operation, intraoperative blood loss, anastomotic leak rate, and perioperative complication rate were similar for the two groups. Pathologic complete response rate and overall survival were also similar for the two groups (p=not significant). In multivariable analysis, timing of surgery was not an independent predictor of perioperative complication, pathologic complete response, or overall survival.

Conclusions: The timing of esophagectomy after neoadjuvant CXRT is not associated with perioperative complication, pathologic response, or overall survival. It may be reasonable to delay esophagectomy beyond 8 weeks for patients who have not yet recovered from chemoradiation.

Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

PubMed Disclaimer

Figures

Figure 1

Distribution of timing of surgery…

Figure 1

Distribution of timing of surgery after CXRT.

Figure 1

Distribution of timing of surgery after CXRT.

Figure 2

Kaplan-Meier curve for overall survival.…

Figure 2

Kaplan-Meier curve for overall survival. p = 0.23.

Figure 2

Kaplan-Meier curve for overall survival. p = 0.23.

Figure 3

Kaplan-Meier curve for disease free…

Figure 3

Kaplan-Meier curve for disease free survival. p=0.17.

Figure 3

Kaplan-Meier curve for disease free survival. p=0.17.

Similar articles Cited by References
    1. Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8(3):226–234. - PubMed
    1. Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008;26(7):1086–1092. - PMC - PubMed
    1. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335(7):462–467. - PubMed
    1. Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997;337(3):161–167. - PubMed
    1. Burmeister BH, Smithers BM, Gebski V, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol. 2005;6(9):659–668. - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3